Updates on the Epidemiology of the Human T-Cell Leukemia Virus Type 1 Infection in the Countries of the Eastern Mediterranean Regional Office of the World Health Organization with Special Emphasis on the Situation in Iran

dc.contributor.authorHedayati-Moghaddam, Mohammad Reza
dc.contributor.authorEsfehani, Reza Jafarzadeh
dc.contributor.authorEl-Hajj, Hiba Ahmad
dc.contributor.authorBazarbachi, Ali Abdul Hamid
dc.contributor.departmentExperimental Pathology, Microbiology, and Immunology
dc.contributor.departmentInternal Medicine
dc.contributor.departmentAnatomy, Cell Biology, and Physiological Sciences
dc.contributor.facultyFaculty of Medicine (FM)
dc.contributor.institutionAmerican University of Beirut
dc.date.accessioned2025-01-24T11:39:11Z
dc.date.available2025-01-24T11:39:11Z
dc.date.issued2022
dc.description.abstractBackground: The epidemiology and prevalence of the Human T-cell leukemia virus type-1 (HTLV-1) infection represent a recommended priority by global health agencies. An in-depth revision to update the status of this infection in countries including those of the Eastern Mediterranean Regional Office (EMRO) of the World Health Organization is hence required. Methods: Ninety-seven studies evaluating the HTLV-1 infection in low-and high-risk populations in EMRO countries were retrieved from the international electronic databases and were used to assess the epidemiological status of the infection in these countries. Results: Most epidemiologic reports were published from Iran, with more than 50% of Iranian prisoners and around 4% of healthy individuals reported to have the infection. In Egypt, a considerable prevalence of the virus spans around 1.11% of blood donors. Foci of HTLV-1 infection are also present in some countries and require a careful epidemiological evaluation. In the other EMRO countries, a lower prevalence that does not exceed 1% was reported. Conclusion: The epidemiology and prevalence of HTLV-1 in the EMRO countries require a tight revision and update. Published studies reveal a scarce distribution of the virus in the African countries of EMRO, while a lower prevalence is denoted in the Asian countries of EMRO, except in Iran, where the prevalence is high. © 2022 by the authors. Licensee MDPI, Basel, Switzerland.
dc.identifier.doihttps://doi.org/10.3390/v14040664
dc.identifier.eid2-s2.0-85127723286
dc.identifier.pmid35458394
dc.identifier.urihttp://hdl.handle.net/10938/29202
dc.language.isoen
dc.publisherMDPI
dc.relation.ispartofViruses
dc.sourceScopus
dc.subjectAfrican countries of emro
dc.subjectAsian countries of emro
dc.subjectEastern mediterranean region
dc.subjectEpidemiology
dc.subjectHuman t-lymphotropic virus 1
dc.subjectPrevalence
dc.subjectHtlv-i infections
dc.subjectHumans
dc.subjectIran
dc.subjectLeukemia, t-cell
dc.subjectWorld health organization
dc.subjectAdult
dc.subjectAutoimmune disease
dc.subjectBlood donor
dc.subjectBlood transfusion
dc.subjectBreast feeding
dc.subjectCarcinoma
dc.subjectCardiovascular disease
dc.subjectChemiluminescence immunoassay
dc.subjectDiabetes mellitus
dc.subjectDisease transmission
dc.subjectDrug abuse
dc.subjectDrug dependence
dc.subjectFemale
dc.subjectGenotype
dc.subjectHealth care system
dc.subjectHemodialysis
dc.subjectHtlv-1 infection
dc.subjectHuman
dc.subjectHuman immunodeficiency virus infection
dc.subjectImmunoblotting
dc.subjectMale
dc.subjectNeurologic disease
dc.subjectParesthesia
dc.subjectPhylogeny
dc.subjectPrisoner
dc.subjectReview
dc.subjectRisk factor
dc.subjectSystematic review
dc.subjectTendon reflex
dc.subjectThalassemia
dc.subjectWestern blotting
dc.subjectT cell leukemia
dc.titleUpdates on the Epidemiology of the Human T-Cell Leukemia Virus Type 1 Infection in the Countries of the Eastern Mediterranean Regional Office of the World Health Organization with Special Emphasis on the Situation in Iran
dc.typeReview

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
2022-1829.pdf
Size:
2.78 MB
Format:
Adobe Portable Document Format